FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nico van Tilburg

Research Profile

Chemicals & Drugs

Procedures

Disorders

Physiology

Concepts & Ideas

Anatomy

ABO Blood-Group System

Co-author Network

Publications

TOP 3
Annelies E Berden; Sarah L Nolan; Hannah L Morris; Rogier M Bertina; Dianhdra D Erasmus; Chris Hagen; Donal P Hayes; Nico H van Tilburg; Jan A Bruijn; Caroline O S Savage; Ingeborg M Bajema; Peter Hewins
Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis.
Vania M Morelli; Marieke C H de Visser; Nico H van Tilburg; Hans L Vos; J C J Eikenboom; Frits R Rosendaal; Rogier M Bertina
ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
A Yaël Nossent; Vincent Van Marion; Nico H van Tilburg; Frits R Rosendaal; Rogier M Bertina; J A VAN Mourik; H C J Eikenboom
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nico van Tilburg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Annelies E Berden; Sarah L Nolan; Hannah L Morris; Rogier M Bertina; Dianhdra D Erasmus; Chris Hagen; Donal P Hayes; Nico H van Tilburg; Jan A Bruijn; Caroline O S Savage; Ingeborg M Bajema; Peter Hewins
Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis.
Journal of the American Society of Nephrology : JASN 2010;21(12):2169-79.
2007: Vania M Morelli; Marieke C H de Visser; Nico H van Tilburg; Hans L Vos; J C J Eikenboom; Frits R Rosendaal; Rogier M Bertina
ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Thrombosis and haemostasis 2007;97(4):534-41.
2006: A Yaël Nossent; Vincent Van Marion; Nico H van Tilburg; Frits R Rosendaal; Rogier M Bertina; J A VAN Mourik; H C J Eikenboom
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2556-62.
2006: Rogier M Bertina; Nico H van Tilburg; Frits Haverkate; Bonno N Bouma; Peter A von dem Borne; Joost C M Meijers; W Campbell; D Eaton; Dirk F Hendriks; Johan L Willemse
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI).
Journal of thrombosis and haemostasis : JTH 2006;4(1):256-7.
2004: Ana H C Guimarães; Nico H van Tilburg; Hans L Vos; Rogier M Bertina; Dingeman C Rijken
Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays.
British journal of haematology 2004;124(5):659-65.
2001: Iris J A M Jonkers; Frits H A F de Man; Nico H van Tilburg; Arnoud van der Laarse; Per Morten Sandset; August Smelt; Rogier M Bertina
Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(8):705-12.
2001: Geert-Jan Brouwers; Hans L Vos; Frank W G Leebeek; Saskia Bulk; M Schneider; Michael B Boffa; Marlys L Koschinsky; Nico H van Tilburg; Michael E Nesheim; Rogier M Bertina; E B Gómez Garcia
A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels.
Blood 2001;98(6):1992-3.
2000: Nico H van Tilburg; Frits R Rosendaal; Rogier M Bertina
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.
Blood 2000;95(9):2855-9.